Smith & Wesson Brands (SWBI)
(Delayed Data from NSDQ)
$16.89 USD
-0.18 (-1.03%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $16.90 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Smith & Wesson Brands, Inc falls in the month of April .
All items in Millions except EPS data.
4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 | |
---|---|---|---|---|---|
Sales | 479 | 864 | 1,059 | 678 | 638 |
Cost Of Goods | 325 | 490 | 610 | 444 | 412 |
Gross Profit | 155 | 375 | 449 | 235 | 226 |
Selling & Adminstrative & Depr. & Amort Expenses | 106 | 123 | 129 | 284 | 188 |
Income After Depreciation & Amortization | 48 | 252 | 320 | -49 | 38 |
Non-Operating Income | 0 | 3 | 2 | 0 | 0 |
Interest Expense | 0 | 2 | 4 | 11 | 9 |
Pretax Income | 48 | 252 | 318 | -60 | 29 |
Income Taxes | 11 | 58 | 74 | 1 | 10 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 37 | 194 | 244 | -61 | 18 |
Extras & Discontinued Operations | 0 | 0 | 8 | 0 | 0 |
Net Income (GAAP) | 37 | 194 | 252 | -61 | 18 |
Depreciation Footnote | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 80 | 282 | 351 | 104 | 102 |
Depreciation & Amortization (Cash Flow) | 31 | 30 | 32 | 153 | 64 |
Income After Depreciation & Amortization | 48 | 252 | 320 | -49 | 38 |
Earnings Per Share Data | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Average Shares | 46.17 | 47.73 | 55.35 | 54.98 | 55.22 |
Diluted EPS Before Non-Recurring Items | 0.94 | 4.25 | 4.53 | 0.82 | 0.83 |
Diluted Net EPS (GAAP) | 0.80 | 4.08 | 4.55 | -1.11 | 0.33 |
Fiscal Year end for Smith & Wesson Brands, Inc falls in the month of April .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 137.48 | 124.96 | 114.24 | 144.78 | 129.04 |
Cost Of Goods | 98.06 | 93.19 | 83.84 | 102.81 | 87.20 |
Gross Profit | 39.42 | 31.77 | 30.40 | 41.96 | 41.84 |
SG&A, R&D, and Dept/Amort Expenses | 28.14 | 27.99 | 26.05 | 24.14 | 27.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 11.28 | 3.78 | 4.35 | 17.82 | 14.14 |
Non-Operating Income | -0.01 | 0.14 | 0.20 | -2.15 | 0.84 |
Interest Expense | 0.96 | 0.65 | 0.00 | -1.03 | 0.51 |
Pretax Income | 10.32 | 3.26 | 4.55 | 16.70 | 14.47 |
Income Taxes | 2.43 | 0.77 | 1.43 | 3.87 | 3.39 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 7.88 | 2.50 | 3.12 | 12.84 | 11.08 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 7.88 | 2.50 | 3.12 | 12.84 | 11.08 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 46.03 | 46.36 | 46.55 | 46.28 | 46.17 |
Diluted EPS Before Non-Recurring Items | 0.19 | 0.14 | 0.13 | 0.32 | 0.25 |
Diluted Net EPS (GAAP) | 0.17 | 0.05 | 0.07 | 0.28 | 0.24 |